Table TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 [see all tables in this series...]

Part (iv) Ratio of males to females among all clients entering inpatient treatment

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Base (known status)
Bulgaria	(1)	6.1								525
Czech Republic		2.2		1.6	0.8	2.0	4.2	2.4	1.0	1843
Denmark	(2)	3.2	3.8	5.0	4.0			4.1	14.0	341
Germany	(3)	4.2	8.8	5.1	0.6	2.0		7.3	3.1	6912
Ireland	(4)	2.8	6.3	12.5	2.5		2.0	6.3	0.0	952
Greece	(5)	5.6	5.8	8.0	4.6			4.0	1.3	1855
France	(6)	4.2	7.5	2.5	1.9	5.0	2.0	4.1	13.5	390
Cyprus	(7)	4.2	8.5	0.0				3.0		123
Latvia		2.9		3.0	1.5			7.0	6.0	626
Luxembourg	(8)	2.6	2.3							117
Hungary	(9)	3.2	4.3	1.1	0.5	5.3	5.2	4.8	1.7	4967
Austria	(10)	2.7	3.2	3.4	3.7			7.2		1181
Slovakia		3.4		4.0	0.5		5.6	4.5		528
Finland	(11)	2.0		2.1	1.8		1.5	4.5	2.0	986
Sweden		2.6	7.5	1.9	1.6	2.0		6.4	3.1	2818
United Kingdom	(12)	2.5	2.3	1.7	1.6		2.0	1.5	1.2	3346
Turkey		16.4	10.8	8.8	4.4		47.8	31.5	6.0	2796
Total		3.6	4.4	2.0	0.7	5.4	11.4	7.2	2.9	2.7
Total base		14142	1477	3567	4312	77	535	3933	2263	30306

Notes:

 (1) No female cases for cocaine and volatile substances; no cases for hallucinogens and other drugs. 

 (2) No cases for hallucinogens and volatile substances. 

 (3) No female cases for cannabis. 

 (4) No female cases for hallucinogens and other drugs; no cases for Volatile substances. 

 (5) No female cases for stimulants and other drugs; no cases for hallucinogens and volatile substances. 

 (6) No male cases for hypnotics; no female cases for cannabis and cocaine; no cases for hallucinogens, stimulants, volatile substances and other drugs. 

 (7) No cases for hallucinogens, hypnotics, volatile substances and other drugs. 

 (8) No cases for hallucinogens. 

 (9) No female cases for hallucinogens. 

 (10) No female cases for cocaine, hallucinogens and other drugs. 

 (11) No female cases for hallucinogens. 

 (12) No cases for hallucinogens. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — TDI — inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)